| Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination J Yu, MD Green, S Li, Y Sun, SN Journey, JE Choi, SM Rizvi, A Qin, ... Nature medicine 27 (1), 152-164, 2021 | 535 | 2021 |
| Linking genes of unknown function with abiotic stress responses by high‐throughput phenotype screening S Luhua, A Hegie, N Suzuki, E Shulaev, X Luo, D Cenariu, V Ma, S Kao, ... Physiologia plantarum 148 (3), 322-333, 2013 | 127 | 2013 |
| Characterization of Arabidopsis NEET Reveals an Ancient Role for NEET Proteins in Iron Metabolism R Nechushtai, AR Conlan, Y Harir, L Song, O Yogev, ... The Plant Cell 24 (5), 2139-2154, 2012 | 102 | 2012 |
| Virus-positive Merkel cell carcinoma is an independent prognostic group with distinct predictive biomarkers KL Harms, L Zhao, B Johnson, X Wang, S Carskadon, N Palanisamy, ... Clinical Cancer Research 27 (9), 2494-2504, 2021 | 52 | 2021 |
| Ipilimumab induced digital vasculitis A Padda, E Schiopu, J Sovich, V Ma, A Alva, L Fecher Journal for ImmunoTherapy of Cancer 6, 1-5, 2018 | 44 | 2018 |
| Successful use of secukinumab in two melanoma patients with immune checkpoint inhibitor-induced inflammatory arthropathy VT Ma, CD Lao, LA Fecher, E Schiopu Immunotherapy 14 (8), 593-598, 2022 | 18 | 2022 |
| Validation of the American Joint Committee on cancer eighth edition staging of patients with metastatic cutaneous melanoma treated with immune checkpoint inhibitors JJ Waninger, VT Ma, S Journey, J Skvarce, Z Chopra, A Tezel, AK Bryant, ... JAMA Network Open 4 (3), e210980-e210980, 2021 | 16 | 2021 |
| The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naive advanced stage melanoma VT Ma, S Daignault‐Newton, JJ Waninger, S Journey, Z Chopra, A Tezel, ... Pigment Cell & Melanoma Research 34 (3), 629-640, 2021 | 11 | 2021 |
| Viral status predicts the patterns of genome methylation and decitabine response in merkel cell carcinoma PW Harms, ME Verhaegen, JN Vo, JC Tien, D Pratt, F Su, ... Journal of Investigative Dermatology 142 (3), 641-652, 2022 | 10 | 2022 |
| Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors VT Ma, CT Su, M Hu, JMG Taylor, S Daignault-Newton, O Kellezi, ... Urologic Oncology: Seminars and Original Investigations 39 (7), 437. e1-437. e9, 2021 | 10 | 2021 |
| NB-UVB phototherapy in the treatment of anti-PD-1 inhibitor induced psoriasis: A case report VT Ma, CS Katzman, PL Palmbos, RM Patel, JE Gudjonsson, AS Alva Current Problems in Cancer: Case Reports 1, 100004, 2020 | 8 | 2020 |
| Targeted therapy and traditional chemotherapy in melanoma and cutaneous squamous cell carcinoma VT Ma, CT Haring, G Warrier, PL Swiecicki Facial Plastic Surgery 36 (02), 186-193, 2020 | 6 | 2020 |
| Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy V Pozorski, Y Park, Y Mohamoud, D Tesfamichael, H Emamekhoo, ... Pigment Cell & Melanoma Research 36 (6), 501-511, 2023 | 3 | 2023 |
| Acquired hypolipoproteinemia and hemophagocytic lymphohistiocytosis: A previously unexplored association? LE Reap, VT Ma, R Takiar, AM Forman Journal of Clinical Oncology 39 (15_suppl), e19041-e19041, 2021 | 3 | 2021 |
| Phase 1 trial of GD2-SADA:177Lu-DOTA drug complex in patients with recurrent or refractory metastatic solid tumors known to express GD2 including small cell … TK Owonikoko, JC Moser, J Yoon, EK Slotkin, A Dowlati, VT Ma, M Düring, ... Journal of Clinical Oncology 41 (16_suppl), TPS3162-TPS3162, 2023 | 2 | 2023 |
| Early response assessment in advanced stage melanoma treated with combination ipilimumab/nivolumab VT Ma, AA Chamila Perera, Y Sun, M Sitto, JJ Waninger, G Warrier, ... Frontiers in Immunology 13, 860421, 2022 | 2 | 2022 |
| Increased incidence of immune-mediated myocarditis in advanced skin malignancies treated with immune checkpoint inhibitors in the COVID-19 era. A Gradone, VT Ma, LA Fecher, SE Yentz, A Vasbinder, SS Hayek, CD Lao Journal of Clinical Oncology 40 (16_suppl), 2664-2664, 2022 | 2 | 2022 |
| Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform D King, CE Foucar, V Ma, L Benitez, AJ Perissinotti, BL Marini, ... Cancer Genetics 258, 57-60, 2021 | 2 | 2021 |
| 241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab V Ma, K Griffith, J Waninger, S Daignault-Newton, L Fecher, A Alva, C Lao Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 2 | 2020 |
| Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis JJ Waninger, VT Ma, Z Chopra, AN Pearson, MD Green The Cancer Journal 29 (5), 279-284, 2023 | 1 | 2023 |
